Tolvarise 30mg Tablet
Marketer
Tas Med India Pvt Ltd
Salt Composition
Tolvaptan (30mg)
Overview Tolvarise 30mg Tablet
Contiose 30mg tablets are indicated for managing hyponatremia, a deficiency of sodium in the bloodstream. This condition can stem from various underlying health issues, including heart failure, liver cirrhosis, and syndrome of inappropriate antidiuretic hormone secretion (SIADH). Contiose 30mg tablets may be administered with or without food, always adhering strictly to your physician's prescribed dosage and frequency. Consistent use is crucial for optimal therapeutic effect; discontinue only under your doctor's guidance. Commonly reported side effects include increased urinary frequency, nocturia (excessive nighttime urination), dry mouth, heightened thirst, nausea, elevated creatinine levels, hyperkalemia, and constipation. Report any persistent or worsening side effects to your doctor. Prior to commencing treatment, disclose any kidney or liver impairment to your healthcare provider. Regular blood sodium level monitoring will be conducted throughout your treatment. Complete disclosure of all other medications you are currently using is also essential.
Primary Ingredients of Tolvarise 30mg Tablet
No text was provided to rewrite.
Uses of Tolvarise 30mg Tablet
Managing hyponatremia
Major Benefits of Tolvarise 30mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Tolvarise 30mg Tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Tolvarise 30mg Tablet:
- Frequent urge to urinate
- Nocturia (increased urge to urinate during the night)
- Dryness in mouth
- Increased thirst
- Constipation
- Nausea
- Increased creatinine level in blood
- Increased potassium level in blood
How to use Tolvarise 30mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 30mg Tolvarise tablet whole; avoid chewing, crushing, or breaking it. While food is not required, consistent timing is recommended for optimal results.
How Tolvarise 30mg Tablet works:
Tolvarise 30mg tablets counteract the action of vasopressin. By inhibiting vasopressin's effects, they promote diuresis, lower blood volume, and elevate serum sodium concentration.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Tolvarise 30mg Tablet concurrently with alcohol. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Tolvarise 30mg tablets during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Tolvarise 30mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking a Tolvarise 30mg tablet might reduce alertness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Tolvarise 30mg tablets are considered safe for individuals with kidney impairment; no dosage modification is necessary. Nevertheless, Tolvarise 30mg tablets are not advised for patients experiencing severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Tolvarise 30mg tablets cautiously, potentially requiring dosage modification. Consult a physician before use. Tolvarise 30mg tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Tolvarise 30mg Tablet :
Should you forget a Tolvarise 30mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Tolvarise 30mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Benzazepine-based compound |
| Developing Habits | No. |
| Treatment Category | Urological Care |
| Actions | V2 receptor blocker |



